Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: URN022
MIFTS: 34

Urinary Tract Infections, Recurrent

Categories: Nephrological diseases
Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Urinary Tract Infections, Recurrent

About this section

MalaCards integrated aliases for Urinary Tract Infections, Recurrent:

Name: Urinary Tract Infections, Recurrent 58
Urinary Tract Infections, Recurrent, Susceptibility to 58 30
Recurrent Urinary Tract Infections 30
Urinary Tract Infection Recurrent 56
Recurrent Urinary Tract Infection 74

Classifications:

MalaCards categories:
Anatomical: Nephrological diseases
See all MalaCards categories (disease lists)


External Ids:

OMIM 58 603806
UMLS 74 C0262655
Sources

Summaries for Urinary Tract Infections, Recurrent

About this section
MalaCards based summary : Urinary Tract Infections, Recurrent, also known as urinary tract infections, recurrent, susceptibility to, is related to acute cystitis and ectrodactyly and ectodermal dysplasia without cleft lip/palate. An important gene associated with Urinary Tract Infections, Recurrent is CXCR1 (C-X-C Motif Chemokine Receptor 1). The drugs Cranberry and Levofloxacin have been mentioned in the context of this disorder. Affiliated tissues include kidney, spinal cord and testes.

Description from OMIM: 603806
Sources

Related Diseases for Urinary Tract Infections, Recurrent

About this section

Diseases related to Urinary Tract Infections, Recurrent via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 53)
# Related Disease Score Top Affiliating Genes
1 acute cystitis 11.8
2 ectrodactyly and ectodermal dysplasia without cleft lip/palate 11.2
3 ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1 11.2
4 hypomagnesemia 3, renal 11.2
5 actg2-related disorders 11.2
6 familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis 11.2
7 hereditary xanthinuria 11.2
8 vesicoureteral reflux 1 10.4
9 cystitis 10.3
10 bacteriuria 10.3
11 interstitial cystitis 10.1
12 cystitis cystica 10.1
13 sexual disorder 10.1
14 prostatitis 10.1
15 prostatic adenoma 10.1
16 biliary cirrhosis, primary, 1 10.0
17 pelvic organ prolapse 10.0
18 prostatic hyperplasia, benign 10.0
19 primary biliary cirrhosis 10.0
20 spinal cord injury 10.0
21 pyuria 10.0
22 urethral diverticulum 10.0
23 primary biliary cholangitis 10.0
24 idiopathic hypercalciuria 10.0
25 bladder cancer 9.8
26 hepatocellular carcinoma 9.8
27 pheochromocytoma 9.8
28 cerebrotendinous xanthomatosis 9.8
29 mckusick-kaufman syndrome 9.8
30 polydactyly 9.8
31 caronte 9.8
32 leukemia, acute lymphoblastic 9.8
33 acute lymphocytic leukemia 9.8
34 bartter disease 9.8
35 leukemia 9.8
36 neutropenia 9.8
37 hemorrhagic cystitis 9.8
38 endocarditis 9.8
39 lymphocytic leukemia 9.8
40 hypospadias 9.8
41 bladder calculus 9.8
42 pyelonephritis 9.8
43 constipation 9.8
44 cystadenoma 9.8
45 adenocarcinoma 9.8
46 rhabdomyosarcoma 9.8
47 pleomorphic rhabdomyosarcoma 9.8
48 mood disorder 9.8
49 vaginal discharge 9.8
50 hypokalemia 9.8

Graphical network of the top 20 diseases related to Urinary Tract Infections, Recurrent:



Diseases related to Urinary Tract Infections, Recurrent
Sources

Symptoms & Phenotypes for Urinary Tract Infections, Recurrent

About this section

Clinical features from OMIM:

603806
Sources

Drugs & Therapeutics for Urinary Tract Infections, Recurrent

About this section

Drugs for Urinary Tract Infections, Recurrent (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 605)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Cranberry Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
2
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 100986-85-4 149096
3
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 82419-36-1 4583
4
Nitrofurantoin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 67-20-9 5353830
5
Trimethoprim Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 738-70-5 5578
6
Sulbactam Approved Phase 4,Phase 3,Phase 2 68373-14-8
7
Piperacillin Approved Phase 4,Phase 3,Phase 2,Not Applicable 66258-76-2 43672
8
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Not Applicable 55-56-1 2713 9552079
9
Povidone-iodine Approved Phase 4,Phase 2,Not Applicable 25655-41-8
10
Iodine Approved, Investigational Phase 4,Phase 2,Not Applicable 7553-56-2 807
11
Povidone Approved Phase 4,Phase 2,Not Applicable 9003-39-8
12
acetic acid Approved Phase 4 64-19-7 176
13 Apricot Approved Phase 4
14
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 9004-61-9 53477741
15
Vancomycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 1404-90-6 441141 14969
16
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 26787-78-0 33613
17
Clavulanate Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 58001-44-8 5280980
18
Imipenem Approved Phase 4,Phase 3,Phase 2 74431-23-5, 64221-86-9 104838
19
Azithromycin Approved Phase 4,Not Applicable 83905-01-5 55185 447043
20
Cefoxitin Approved Phase 4,Not Applicable 35607-66-0 441199
21
Ciprofloxacin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 85721-33-1 2764
22
Cefotaxime Approved Phase 4,Not Applicable 63527-52-6 456256 5742673
23
Finasteride Approved Phase 4 98319-26-7 57363
24
Tamsulosin Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 106133-20-4 129211
25
Bethanechol Approved Phase 4 674-38-4 2370
26
Metronidazole Approved Phase 4,Phase 3,Not Applicable,Early Phase 1 443-48-1 4173
27
Tranexamic Acid Approved Phase 4,Phase 3,Not Applicable 1197-18-8 5526
28
Methenamine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 100-97-0 4101
29
leucovorin Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 58-05-9 6006 143
30
Sulfamethoxazole Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 723-46-6 5329
31
Fosfomycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 23155-02-4 446987
32
Acetylcholine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1,Not Applicable 51-84-3 187
33
Cephalexin Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 15686-71-2 27447
34
Cefuroxime Approved Phase 4,Not Applicable,Early Phase 1 55268-75-2 5361202 5479529
35
Ertapenem Approved, Investigational Phase 4,Phase 3,Phase 2 153832-46-3 150610
36
Ampicillin Approved, Vet_approved Phase 4,Not Applicable 69-53-4 6249
37
Ceftriaxone Approved Phase 4,Phase 3,Phase 2 73384-59-5 5479530 5361919
38
Cefazolin Approved Phase 4,Phase 3,Phase 1,Not Applicable 25953-19-9 656510 33255
39
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Not Applicable 302-25-0
40
Mycophenolic acid Approved Phase 4,Phase 2,Phase 1,Not Applicable 24280-93-1 446541
41
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 50-24-8 5755
42
Tacrolimus Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 104987-11-3 445643 439492 6473866
43
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 83-43-2 6741
44
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Not Applicable 2921-57-5
45
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Not Applicable 51-43-4 5816
46
Racepinephrine Approved Phase 4,Phase 3,Not Applicable 329-65-7 838
47
Tobramycin Approved, Investigational Phase 4 32986-56-4 5496 36294
48
Empagliflozin Approved Phase 4,Phase 2,Not Applicable 864070-44-0
49
Polymyxin B Approved, Vet_approved Phase 4,Phase 3,Not Applicable 1404-26-8
50
Zinc Approved, Investigational Phase 4,Phase 3,Not Applicable 7440-66-6 32051

Interventional clinical trials:

(show top 50) (show all 1050)
# Name Status NCT ID Phase Drugs
1 Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women Unknown status NCT00900653 Phase 4 Gynoflor E (low dose estriol with lactobacillus)
2 Cranberry for the Prevention of Urinary Tract Infections Unknown status NCT02454309 Phase 4
3 The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females Unknown status NCT02094703 Phase 4 Levofloxacin;Solifenacin succinate;Placebo (for Solifenacin succinate)
4 Effects of Antibiotic Prophylaxis on Recurrent UTI in Children Unknown status NCT02357758 Phase 4 Antibiotic Prophylaxis
5 Gentamicin Bladder Instillation Trial Unknown status NCT01884467 Phase 4 Gentamicin;Placebo
6 Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection Unknown status NCT00156546 Phase 4 antibiotic to reduce the recurrence of infection
7 Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection Unknown status NCT01897831 Phase 4 xin te mie
8 BIP Foley in Prevention of CAUTI at Rehab Station Unknown status NCT02808000 Phase 4
9 The Impact of Antimicrobial Treatment for Asymptomatic Bacteriuria in Renal Transplant Patients Unknown status NCT02113774 Phase 4
10 Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection Unknown status NCT01760109 Phase 4 Piperacillin Sodium and Sulbactam Sodium
11 Effect of Chlorhexidine on Bacteriuria Unknown status NCT02032394 Phase 4 Povidone-iodine;Chlorhexidine;Normal saline
12 Bladder Lavage as Decontamination Method for Asymptomatic Bacteriuria With Uropathogens in Catheterized Patients Unknown status NCT01772875 Phase 4
13 Vaginal and Urinary Microbiome Trial Unknown status NCT02869165 Phase 4 Premarin vaginal cream;Apricot kernel oil
14 Clinical Impact of Bacteriuria on Chronic Inflammation in Asymptomatic Hemodialysis Patients Unknown status NCT01570556 Phase 4
15 A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children Unknown status NCT02271035 Phase 4 Deflux;Vantris
16 Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis Unknown status NCT01820026 Phase 4 Imipenem;Vancomycin;azithromycin;Cefotaxime;Amoxicillin
17 Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients Unknown status NCT01736033 Phase 4 Tamsulosin;Finasteride;Placebo
18 Efficiency of Cold vs. Laser Internal Urethrotomy Treatment of Urethral Strictures Unknown status NCT01196572 Phase 4
19 Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA Unknown status NCT02910596 Phase 4 bethanechol chloride
20 Effect of Enteral Genistein Supplementation in Sepsis Unknown status NCT02796794 Phase 4
21 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
22 Ciprofloxacin for Prevention of BK Infection Unknown status NCT01789203 Phase 4 Ciprofloxacin;placebo
23 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
24 Tranexamic Acid in Knee Joint Surgery Unknown status NCT02278263 Phase 4 Tranexamic Acid;Normal saline (0.9% NaCl)
25 The Effect of Chest Tubes Using Active Clearance Technology® on the Incidence of Postoperative Atrial Fibrillation Unknown status NCT02808897 Phase 4
26 Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs Active, not recruiting NCT03077711 Phase 4 Trimethoprim;Methenamine hippurate
27 Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients Completed NCT03235947 Phase 4 Fosfomycin disodium;Trimethoprim / Sulfamethoxazole;Intravenous placebo
28 Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection Recruiting NCT03508921 Phase 4 Extended Antibiotics
29 Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI) Completed NCT01450800 Phase 4 Nitrofurantoin;Placebo
30 Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection Recruiting NCT03099863 Phase 4 Cystoscopic Fluid containing Neosporin G. U. Irrigant;Cystoscopic Fluid/Placebo
31 Clinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract Infection Not yet recruiting NCT03658291 Phase 4 Sanjin tablets;Sanjin tablets simulants;Levofloxacin
32 Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection Withdrawn NCT02034890 Phase 4 Hyaluronic Acid
33 Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections Completed NCT00318591 Phase 4
34 Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults Completed NCT01092351 Phase 4 Nitrofurantoin
35 Cranberry on Urinary Tract Infections Withdrawn NCT01881165 Phase 4 Cranberry;Placebo
36 Febrile Urinary Tract Infection Randomized Short Treatment Trial Completed NCT00809913 Phase 4 short treatment (ciprofloxacin)
37 Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial Recruiting NCT03151603 Phase 4 Arctuvan;Fosfomycin;Placebo to Arctuvan;Placebo to Fosfomycin
38 Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder Completed NCT01388413 Phase 4 Weekly Oral Cyclic Antibiotic programme
39 Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery Recruiting NCT03287089 Phase 4 Nitrofurantoin 100 MG;Placebo Oral Tablet
40 Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens Completed NCT00481689 Phase 4 Cipro XR (Ciprofloxacin, BAYQ3939)
41 Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections Completed NCT00669994 Phase 4 Ciprofloxacin
42 Preventing Recurrent Urinary Tract Infections With α-D-mannose Recruiting NCT03497598 Phase 4 Mannose;Lactose
43 Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI) Completed NCT03366207 Phase 4 Ciprofloxacin
44 Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation Completed NCT01820897 Phase 4 Fosfomycin-Trometamol;Sulfamethoxazole trimethoprim
45 Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women Active, not recruiting NCT01966653 Phase 4 nitrofurantoin;fosfomycin
46 Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI Completed NCT01488955 Phase 4 Ibuprofen;Fosfomycin-Trometamol
47 INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI Recruiting NCT03299387 Phase 4 Nitrofurantoin;Gentamicin
48 Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli Terminated NCT02474706 Phase 4 Cefoxitin;imipenem
49 Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time Terminated NCT00245791 Phase 4 Levofloxacin
50 Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae Active, not recruiting NCT02681263 Phase 4 Temocillin

Search NIH Clinical Center for Urinary Tract Infections, Recurrent

Sources

Genetic Tests for Urinary Tract Infections, Recurrent

About this section

Genetic tests related to Urinary Tract Infections, Recurrent:

# Genetic test Affiliating Genes
1 Urinary Tract Infections, Recurrent, Susceptibility to 30
2 Recurrent Urinary Tract Infections 30
Sources

Anatomical Context for Urinary Tract Infections, Recurrent

About this section

MalaCards organs/tissues related to Urinary Tract Infections, Recurrent:

42
Kidney, Spinal Cord, Testes, Colon, Prostate, Skin, Brain
Sources

Publications for Urinary Tract Infections, Recurrent

About this section

Articles related to Urinary Tract Infections, Recurrent:

(show all 50)
# Title Authors Year
1
Stigma and self-management: an Interpretative Phenomenological Analysis of the impact of chronic recurrent urinary tract infections after spinal cord injury. ( 29449969 )
2018
2
An exceptional source of recurrent urinary tract infections in women: Primary retroperitoneal serous cystadenoma. ( 29458894 )
2018
3
Incidental Finding of Urethral Diverticulum in a Woman with History of Recurrent Urinary Tract Infections. ( 29692697 )
2018
4
Role of increasing leukocyturia for detecting the transition from asymptomatic bacteriuria to symptomatic infection in women with recurrent urinary tract infections: A new tool for improving antibiotic stewardship. ( 30008180 )
2018
5
Editorial Comment to Role of increasing leukocyturia for detecting the transition from asymptomatic bacteriuria to symptomatic infection in women with recurrent urinary tract infections: A new tool for improving antibiotic stewardship. ( 30008187 )
2018
6
Native kidney pyelonephritis as the cause of recurrent urinary tract infections in a kidney transplant recipient. ( 29475548 )
2018
7
Recurrent urinary tract infections and low secretory IgA following CD19-directed CAR T-cell therapy for relapsed acute lymphoblastic leukemia. ( 28766894 )
2018
8
Endoscopic Treatment for Vesicoureteral Reflux in Recurrent Urinary Tract Infections in Kidney Transplant: Experience of One Center. ( 29579838 )
2018
9
Delayed diagnosis of primary vesicoureteral reflux in children with recurrent urinary tract infections: Diagnostic approach and renal outcomes. ( 29875036 )
2018
10
The effect of intravesical instillations with Hyaluronic Acid on sexual dysfunction in women with recurrent urinary tract infections (RUTI). ( 29277046 )
2018
11
Recurrent Urinary Tract Infections in a Female Child With Polydactyly and a Pelvic Mass: Consider the McKusick-Kaufman Syndrome. ( 28153592 )
2017
12
Urinary NGAL deficiency in recurrent urinary tract infections. ( 28210838 )
2017
13
Recurrent urinary tract infections in psychotic mood disorders. ( 27908584 )
2017
14
Re: Six out of Ten Women with Recurrent Urinary Tract Infections Complain of Distressful Sexual Dysfunction-A Case-Control Study. ( 28905762 )
2017
15
Six Out of Ten Women with Recurrent Urinary Tract Infections Complain of Distressful Sexual Dysfunction - A Case-Control Study. ( 28295051 )
2017
16
Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction. ( 26647376 )
2016
17
Efficacy of Cranberry in Preventing Recurrent Urinary Tract Infections: Have We Learned Anything New? Commentary on: Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial. ( 28024965 )
2016
18
Complete Genome Sequence of a CTX-M-15-Producing Escherichia coli Strain from the H30Rx Subclone of Sequence Type 131 from a Patient with Recurrent Urinary Tract Infections, Closely Related to a Lethal Urosepsis Isolate from the Patient's Sister. ( 27174264 )
2016
19
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study. ( 28051247 )
2016
20
Autoimmune neutropenia of infancy with recurrent urinary tract infections: a case report. ( 24942028 )
2015
21
Mannose-binding lectin genetic analysis: possible protective role of the HYPA haplotype in the development of recurrent urinary tract infections in men. ( 24321858 )
2014
22
Ultrasound distinction between simple recurrent urinary tract infections and a specific bladder wall inflammatory entity called cystitis cystica. ( 24851610 )
2014
23
The predictive value of urinary UPIb mRNA levels in VUR and recurrent urinary tract infections. ( 24559587 )
2014
24
Efficient and cost-effective alternative treatment for recurrent urinary tract infections and interstitial cystitis in women: a two-case report. ( 25587284 )
2014
25
Ultrasound bladder wall thickness measurement in diagnosis of recurrent urinary tract infections and cystitis cystica in prepubertal girls. ( 23725853 )
2013
26
Urinary Tract Abnormalities In Patients With Recurrent Urinary Tract Infections (UTI) After Hypospadias Repair. ( 24053220 )
2013
27
Case study: Transitional care for a patient with benign prostatic hyperplasia and recurrent urinary tract infections. ( 24079115 )
2013
28
The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? ( 22677710 )
2012
29
Recurrent Urinary Tract Infections due to Asymptomatic Colonic Diverticulitis. ( 22454651 )
2012
30
Asymptomatic proteinuria in a child with recurrent urinary tract infections--questions. ( 21993968 )
2012
31
The clinical effectiveness of intravesical sodium hyaluronate (cystistat®) in patients with interstitial cystitis/painful bladder syndrome and recurrent urinary tract infections. ( 24917721 )
2012
32
Bladder calculus presenting as recurrent urinary tract infections: a late complication of cervical cerclage placement: a case report. ( 21542538 )
2011
33
B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections. ( 22019034 )
2011
34
Complete duplication of collecting system in a horseshoe kidney presenting with recurrent urinary tract infections: report of an exceedingly rare congenital anomaly and review of literature. ( 22224073 )
2011
35
Pheochromocytoma presenting as recurrent urinary tract infections : a case report. ( 21226896 )
2011
36
Recurrent urinary tract infections in an infant with antenatal Bartter syndrome. ( 20127218 )
2011
37
Risk factors for recurrent urinary tract infections in a cohort of patients with primary vesicoureteral reflux. ( 20135833 )
2010
38
Cystitis cystica and recurrent urinary tract infections in children. ( 20977079 )
2010
39
14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up. ( 19933045 )
2009
40
Colonic washout enemas for persistent constipation in children with recurrent urinary tract infections based on dysfunctional voiding. ( 18295312 )
2008
41
Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? ( 17383810 )
2007
42
Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. ( 16339057 )
2005
43
Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men. ( 15610666 )
2005
44
Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men. ( 15260935 )
2004
45
Recurrent urinary tract infections and genitourinary tract abnormalities in the Imerslund-GrAosbeck syndrome. ( 10845232 )
2000
46
Voiding dysfunction associated with incontinence, vesicoureteral reflux and recurrent urinary tract infections. ( 11148732 )
2000
47
[Recurrent urinary tract infections. Biological suppositions and clinical treatment with thymopentin]. ( 9557507 )
1997
48
Comparison of antiadherence activity of bladder extracts from interstitial cystitis patients with recurrent urinary tract infections. ( 1853011 )
1991
49
Ultrasonographic renal parenchymal volume related to kidney function and renal parenchymal area in children with recurrent urinary tract infections and asymptomatic bacteriuria. ( 6391094 )
1984
50
A follow-up study of bacteriuria in female patients treated for recurrent urinary tract infections using dip-slides. ( 4934178 )
1971
Sources

Variations for Urinary Tract Infections, Recurrent

About this section
Sources

Expression for Urinary Tract Infections, Recurrent

About this section
Search GEO for disease gene expression data for Urinary Tract Infections, Recurrent.
Sources

Pathways for Urinary Tract Infections, Recurrent

About this section
Sources

GO Terms for Urinary Tract Infections, Recurrent

About this section
Sources

Sources for Urinary Tract Infections, Recurrent

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....